Eli Lilly (LLY) investors should expect fireworks this week as the pharma giant prepares to drop its bombshell Q4 2024 ...
The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...
An international trial is testing remternetug in young adults at genetic risk for early-onset Alzheimer’s. The study aims to ...
Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, ...
Andrew Natonson, M.D., M.S., Assistant Professor, Neurology Residency Program Director, Director Alzheimer’s Amyloid Clinic, Division of Aging, Alzheimer’s and Related Disorders & Division of ...